Tag: pharmaceuticals
-
Patent Awarded for COPD Dry Powder Inhaler Formula
A formulation for dry powder inhalers to treat respiratory diseases that its developers say delivers medication to the lungs more efficiently received a U.S. patent.
-
Univ. Spin-Off Creating Baby Brain Development Food
A start-up enterprise spun-off from the Duke-NUS medical school in Singapore is licensing research for a new food product for mothers to help a baby’s cognitive development.
-
Trial to Examine Immune System Workings
Unlike conventional clinical studies testing a particular treatment, this trial aims to explore in more detail the body’s interactions with a class of drugs, in this case vaccines.
-
$2 Billion Biotech Licensing Deal Cancelled
A licensing deal with a potential value of more than $2 billion between two biotechnology companies for a new breast cancer drug was cancelled on Friday.
-
Gene Therapy Start-Up Raises $41M in Early Funds
A 1 year-old enterprise developing gene therapies to treat rare inherited metabolic disorders is raising €37.5 million ($US 40.8 million) in its first venture funding round.
-
23andMe, Grünenthal Partner on Pain Genetics
A personal genetics company in Silicon Valley is collaborating with a German pharmaceutical company to better understand the relationship between genetics and pain.
-
Stem Cell Parkinson’s Model Devised for Drug Screening
A team from University at Buffalo created brain cells from adult stem cells that in lab tests display the same nerve misfirings seen in people with Parkinson’s disease.
-
Shire Licensing Dry Eye Disease Treatment in $535M Deal
An experimental drug for treating dry eye disease, a common disorder affecting older individuals, is being licensed by international pharmaceutical company Shire plc.
-
Crispr, Stem Cells Produce Precise Arthritis Therapy
Editing the genes in stem cells is shown to produce cartilage that in lab tests releases therapeutic proteins only when needed to relieve joint inflammation in arthritis.
-
Muscle Supplement Shown Safe, Active in Elderly
A clinical trial testing a dietary supplement to improve muscle function in older persons shows the derivative from pomegranates is safe and produces desired biological actions.